Fostamatinib, an FDA-approved oral small-molecule spleen tyrosine kinase (SYK) inhibitor, is used to treat thrombocytopenia in adults with chronic immune thrombocytopenia (ITP) who have not responded

DataCite Commons2026-04-23 更新60

Grade 3 or 4 clinical events or laboratory abnormalities.

临床试验安全监测

不良事件分析

Grade 3 or 4 clinical events or laboratory abnormalities.

NIAID Data Ecosystem150

Baseline characteristics of the patients with and without adverse events.

心血管疾病

不良事件分析

ADMA = asymmetric dimethylarginine; AF = atrial fibrillation; CAD = coronary artery disease; LVEF = left ventricular ejection fraction; PCI = percutaneous coronary intervention; TIA = tran

NIAID Data Ecosystem60